leisure time -WSS

leisure time

author：explore 2025-09-30 17:59:27 - browse：49

1:56Threshold Glass Jar Candles sold exclusively by Target.U.S. Consumer Product Safety Commission

Target has recalled another 2.2 million of its Threshold candles due to reports of candle jars breaking or cracking during use.

In May, the United States Consumer Product Safety Commission announced the recall of nearly 5 million Target Threshold candle products after the retailer received 137 reports of it breaking or cracking during use.

Now, the Minnesota-based retailer has recalled another 2.2 million candles, the CPC announced Thursday.

"Target received 19 reports of the candle jar breaking or cracking during use, resulting in one minor injury," the agency stated.

MORE: General Motors recalls over 600K cars due to car seat safety issue

Six injuries were reported in the previous recall, including lacerations and severe burns, according to the CPSC.

"This recall involves certain Threshold Glass Jar 5.5 ounce 1-Wick, 14 ounce 3-Wick and 20 ounce 3-Wick Candles in multiple scents," the CPSC stated. "The recalled item numbers are printed on the bottom of the glass jars."

PHOTO: Threshold Glass Jar Candles sold exclusively by Target. — Threshold Glass Jar Candles sold exclusively by Target.U.S. Consumer Product Safety Commission

Click here for a full list of the recalled product details and item numbers.

The CPSC urged consumers to stop using the recalled candles immediately and return them to Target for a refund. Customers can also contact Target for a prepaid return label to send them back by mail.

The candles, which were manufactured in Vietnam, were sold at Target stores nationwide as well as online from August 2019 through March 2023 for between $3 and $20.

An earlier version of this story was originally published May 19, 2023.

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： IVF doctors demand details after CooperSurgical lawsuit

knowledge

WSS

Medicare drug price negotiation continues, as pharma counteroffers

For AI in health care standards, federal regulators join with industry group

Grail is spending more than ever lobbying Congress

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

Immune cells and nerve overgrowth may explain recurring UTI pain

Medicare drug price negotiation hearing pits pharma v Biden admin

hotspot

leisure time

MORE: General Motors recalls over 600K cars due to car seat safety issue

knowledge

Medical records are filled with copy

Medicare drug price negotiation hearing pits pharma v Biden admin

Sports medicine is finally prioritizing gender equality

Option Care buys Amedisys in $3.6 billion home care deal

Drug repurposing or repositioning? The language matters

For AI in health care standards, federal regulators join with industry group

Drug repurposing or repositioning? The language matters

Microsoft's Peter Lee: Generative AI could help doctors be more human

Psychedelics group wrestles with new pharma identity

Fetal cell organoids grown from amniotic fluid, study finds

focus

Pfizer's Covid pill remains 89% effective in final analysis, company says

Listen: Biogen's messy board & Laronde's data problem

When is a doctor not a doctor? Try when patients address women doctors

Streamlined flu vaccines recommended by FDA advisory panel

Listen: Biogen's messy board & Laronde's data problem

Why Talkspace is targeting Medicare, a tricky market

leisure time

knowledge

focus

hotspot